๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II trial of N-methylformamide in advanced head and neck cancer

โœ Scribed by Walter C. Vogel; Arlene A Forastiere; Ronald B. Natale; Bonnie J. Takasugi; Gary Schnur

Publisher
Springer US
Year
1987
Tongue
English
Weight
228 KB
Volume
5
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase ii trial of etoposide and doxorubi
Phase ii trial of etoposide and doxorubicin in advanced head and neck cancer
โœ Gradishar, William J. ;Vokes, Everett E. ;Kies, Merrill S. ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 388 KB

## Abstract In an effort to improve the response rate of patients with advanced head and neck cancer, a clinical trial combining two infrequently studied drugs was conducted. Twelve patients with squamous cell carcinoma of the head and neck were treated with 3โ€day continuous infusions of etoposide

Phase II trial of mitoxantrone in head a
Phase II trial of mitoxantrone in head and neck cancer
โœ Matti S. Aapro; Davis S. Alberts ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Springer US ๐ŸŒ English โš– 136 KB

Mitoxantrone (l,4-dihydroxy-5,8-bis((2-[(2-hydroxyethyl)amino]ethyl)amino)-9, 10 anthracenedione dihydrochloride, NSC 301,739) is a new aminoanthraquinone derivative with clinical activity in the treatment of advanced breast cancer (1, 2), lymphoma (3), and acute leukemia (4). We have carried out a